It is hypothesized that exogenous insulin therapy in T1DM, which bypasses hepatic first-pass metabolism and leads to elevated systemic insulin levels, may contribute to ovarian hyperandrogenism by stimulating theca cells androgen direct or indirect release [4,5]. This evidence concerns the gene INS and type 1 diabetes mellitus.